ES2089357T3 - Formulacion medicinal en forma de aerosol. - Google Patents

Formulacion medicinal en forma de aerosol.

Info

Publication number
ES2089357T3
ES2089357T3 ES92121985T ES92121985T ES2089357T3 ES 2089357 T3 ES2089357 T3 ES 2089357T3 ES 92121985 T ES92121985 T ES 92121985T ES 92121985 T ES92121985 T ES 92121985T ES 2089357 T3 ES2089357 T3 ES 2089357T3
Authority
ES
Spain
Prior art keywords
aerosol
medicinal formulation
medicinal
active substance
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92121985T
Other languages
English (en)
Inventor
Hans-Matthias Dr Deger
Claudia Schutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6448287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2089357(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2089357T3 publication Critical patent/ES2089357T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

SE DESCRIBE UNA PREPARACION MEDICINAL DE AEROSOL, QUE CONTIENE AL MENOS UNA SUSTANCIA MEDICINAL ACTIVA, AL MENOS UNA SUSTANCIA TENSIOACTIVA, ASI COMO HEPTAFLUOROPROPANO, LICUABLE POR COMPRESION, COMO AGENTE PROPULSOR.
ES92121985T 1991-12-31 1992-12-24 Formulacion medicinal en forma de aerosol. Expired - Lifetime ES2089357T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4143263 1991-12-31

Publications (1)

Publication Number Publication Date
ES2089357T3 true ES2089357T3 (es) 1996-10-01

Family

ID=6448287

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92121985T Expired - Lifetime ES2089357T3 (es) 1991-12-31 1992-12-24 Formulacion medicinal en forma de aerosol.

Country Status (8)

Country Link
EP (1) EP0550031B1 (es)
JP (1) JPH05279249A (es)
AT (1) ATE137666T1 (es)
CA (1) CA2086492A1 (es)
DE (1) DE59206234D1 (es)
DK (1) DK0550031T3 (es)
ES (1) ES2089357T3 (es)
SG (1) SG42375A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
ATE144151T1 (de) * 1993-01-19 1996-11-15 Hoechst Ag Flüssiggasformulierung zur vitalitätsprüfung von zähnen
US5679287A (en) 1995-04-28 1997-10-21 Great Lakes Chemical Corporation Uses of heptafluoropropane
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ATE234604T1 (de) 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
DE60042057D1 (de) * 1999-01-29 2009-06-04 Esperanza Peptide Ltd Bukkales verabreichungssystem für proteinhaltige medikamente
EP1169019B1 (en) 1999-04-14 2003-02-26 Glaxo Group Limited Pharmaceutical aerosol formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
PT656206E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos

Also Published As

Publication number Publication date
CA2086492A1 (en) 1993-07-01
DK0550031T3 (da) 1996-08-26
JPH05279249A (ja) 1993-10-26
SG42375A1 (en) 2001-04-17
EP0550031B1 (de) 1996-05-08
DE59206234D1 (de) 1996-06-13
ATE137666T1 (de) 1996-05-15
EP0550031A1 (de) 1993-07-07

Similar Documents

Publication Publication Date Title
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
EP0995434A3 (en) Medicinal aerosol formulations
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
ES2151476T3 (es) Formulaciones de farmacos en aerosol.
EP1736147A3 (en) Non-chlorofluorocarbon aerosol formulations
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
WO1995017156A3 (en) Ethanol substitutes
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
AR004255A1 (es) Formulacion liofilizada farmaceuticamente aceptable constituida por una fase amorfa y una fase cristalina, que comprende por lo menos un principio activo no proteico, y procedimiento para estabilizar el principio activo no proteico contenido en la formulacion liofilizada farmaceuticamente aceptable
EP0701457A4 (en) SYSTEMS FOR INTERPULMONARY ADMINISTRATION OF AQUEOUS SOLUTIONS
TW273550B (es)
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
DK0550031T3 (da) Medicinsk aerosolformulering
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
ES2096014T3 (es) Compuestos esteroides activos sobre el sistema cardiovascular.
DK0626173T3 (da) Aerosolpræparat indeholdende fusafungin
ES2131482A1 (es) Formulacion acuosa de bambuterol.
PT100221A (pt) Dispositivo de libertacao de um agente activo eficiente relativamente ao espaco e a estabilidade
RU1809521C (ru) Генератор плазмы
WO1991013606A3 (de) Verwendung von 3,7-dimethyloctan-1-ol in kosmetischen und dermatologischen präparaten
DE60017450D1 (de) Pharmazeutische formulierungen enthaltend salmeterol
EP0729950A4 (en) ANTI-HIV MEDICINAL PRODUCTS
IL54041A (en) Pharmaceutical compositions for enteral or vaginal application comprising the active ingredient and a nonionic surfactant
EP0509098A4 (en) Ataractic

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 550031

Country of ref document: ES

FG2A Definitive protection

Ref document number: 550031

Country of ref document: ES